Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: A clinical case series

Indian Journal of Ophthalmology

Volumn 54, Issue 3, 2006, Pages 177-183

  Sethi, Harinder ^a   Menon, Vimla ^a   Sharma, Pradeep ^a   Khokhar, Sudarshan ^a   Tandon, Radhika ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dexamethasone; Intravenous steroids; Optic neuritis; Visual outcome

Indexed keywords

DEXAMETHASONE;

ADOLESCENT; ADULT; AFFERENT PUPILLARY DEFECT; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; EVOKED VISUAL RESPONSE; FEMALE; FOLLOW UP; HUMAN; INDIAN; MALE; OPTIC NEURITIS; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL FIELD;

EID: 33748277132     PISSN: 03014738     EISSN: 03014738     Source Type: Journal    
DOI: 10.4103/0301-4738.27069     Document Type: Article

References (13)

1. Earl CJ, Martin B. Prognosis in optic neuritis related to age. Lancet 1967;1:74-6.
2. Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DL, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992a;326:581-8.
3. Beck RW, Cleary PA. The Optic Neuritis Study Group. Optic Neuritis Treatment Trial: One year follow-up results. Arch Ophthalmol 1993;111:773-5.
4. Beck RW, Trobe JD. The Optic Neuritis Treatment Trial (correspondence): Three year follow results. Arch Ophthalmol 1995;13:36-7.
5. The Optic Neuritis Study Group. Optic Neuritis Treatment Trial: Visual function 5 years after optic neuritis. Arch Ophthalmol 1997;115:1554.
6. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone- cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995;34:875-82.
7. Sharada B, Kumar A, Kakker R, Adya CM, Pande I, Uppal SS, et al. Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo controlled study, Rheumatol Int 1994;14:91-4.
8. Mittal R, Agarwal SK, Dash SC, Saxena S, Tiwari SC, Mehta SN, et al. Treatment of acute rejection in live related renal allograft recipients: A comparison of three different protocols. Nephron 1997;77:186-9.
9. Hariharan D, Manno CS, Seri I. Neonatal lupus erythematosus with microvascular hemolysis. J Pediatr Hematol Oncol 2000;22:351-4.
10. La Mantia L, Eoli M, Milanese C, Salmaggi A, Dufour A, Torri V. Double blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol 1994;34:199-203.
11. Keltner JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol 1994;112:946-53.
12. Trobe JD. High Dose corticosteroid regimen retards multiple sclerosis in Optic Neuritis Treatment Trial (Editorial). Arch Ophthalmol 1994;112:35-6.
13. Beck RW, Kupersmith MJ, Cleary PA, Katz B. The Optic Neuritis Study Group. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmol 1993;100:691-8.